What are the Therapeutic Implications of Targeting CD47?
Targeting CD47 has significant therapeutic potential, especially in oncology. Several clinical trials are currently investigating anti-CD47 antibodies and other agents that disrupt the CD47-SIRPα interaction. These therapies aim to boost the immune response against tumors, thereby improving the efficacy of existing treatments and potentially leading to better patient outcomes.
